Home › Funds › Trails Edge Capital Partners, LP › PMN

Trails Edge Capital Partners, LP position in PMN

PROMIS NEUROSCIENCES INC · Health Care

Trails Edge Capital Partners, LP reported holding 557,103 shares of PMN (PROMIS NEUROSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$7.3M, representing 1.16% of its reported portfolio and ranking #30 among its reported holdings. Trails Edge Capital Partners, LP has disclosed PMN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)557.10K sh
Reported value held$7.33M
Portfolio Weight1.16%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's PMN position evolved

Trails Edge Capital Partners, LP first disclosed a stake in PMN in Q1 2026 at 557,103 shares (US$7.1M). The position peaked in Q2 2026 at 557,103 shares, worth US$7.3M. Across 2 filings, Trails Edge Capital Partners, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 557,103 shares valued at US$7.3M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 557.10K $7.08M New
Q2 2026 557.10K $7.33M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PMN and 13F data

PMN (PROMIS NEUROSCIENCES INC) is a Health Care company. 29 other funds we track also report a position in PMN — the largest reported positions include Ally Bridge Group (NY) LLC (US$8.2M), Yu Fan (US$4.3M), Squadron Capital Management LLC (US$4.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PMN

All PMN fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held PMN?

Trails Edge Capital Partners, LP has disclosed PMN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Trails Edge Capital Partners, LP's current position in PMN?

As of Q2 2026, Trails Edge Capital Partners, LP holds 557.10K shares of PMN (PROMIS NEUROSCIENCES INC), valued at $7.33M, representing 1.16% of its reported portfolio and ranking #30.

Has Trails Edge Capital Partners, LP been buying or selling PMN?

In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP held unchanged its position in PMN. The position peaked in Q2 2026 at 557.10K shares.

Which other funds hold PMN?

Other major institutional holders of PMN include Ally Bridge Group (NY) LLC, Yu Fan, Squadron Capital Management LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.